)
Eva Dahlen, PhD
Global Evaluation Director
Novo Nordisk A/S
Dr. Eva Dahlén holds a position as Global Evaluation Director, Search & Evaluation at Novo Nordisk. In this capacity, she takes a leading role in overseeing and managing partnering activities in diabetes. Eva has several year's experience in S&E across a range of technology areas, including RNA & gene therapy, oral and alternative delivery of biologics, and AI/ML-enabled target and drug discovery. She has led numerous due diligences, including those leading to partnerships with Ascendis Pharma and Valo Health. Prior to Novo Nordisk, Eva held various positions in business development and R&D at the immuno-oncology company, Alligator Bioscience. She has a scientific background in immunology and oncology and holds a Ph.D. in immunology.
Sessions
-
23-Jun-2026Theater 2Novo Nordisk
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}